Elevation Oncology, Inc.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in Elevation Oncology, Inc..
Log in to see more information.

News

Elevation Oncology (NASDAQ:ELEV) & Twist Bioscience (NASDAQ:TWST) Head-To-Head Comparison
Elevation Oncology (NASDAQ:ELEV) & Twist Bioscience (NASDAQ:TWST) Head-To-Head Comparison

Ticker Report Twist Bioscience (NASDAQ:TWST - Get Free Report) and Elevation Oncology (NASDAQ:ELEV - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses...\n more…

Head to Head Review: Elevation Oncology (NASDAQ:ELEV) vs. VectivBio (NASDAQ:VECT)
Head to Head Review: Elevation Oncology (NASDAQ:ELEV) vs. VectivBio (NASDAQ:VECT)

Ticker Report Elevation Oncology (NASDAQ:ELEV - Get Free Report) and VectivBio (NASDAQ:VECT - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses...\n more…

Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire...\n more…

Vanguard Group Inc. Acquires 360,799 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV)
Vanguard Group Inc. Acquires 360,799 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV)

Ticker Report Vanguard Group Inc. grew its holdings in Elevation Oncology, Inc. (NASDAQ:ELEV - Free Report) by 30.8% in the 1st quarter, according to its most recent disclosure with the Securities Exchange...\n more…

HC Wainwright Comments on Elevation Oncology, Inc.'s FY2024 Earnings (NASDAQ:ELEV)
HC Wainwright Comments on Elevation Oncology, Inc.'s FY2024 Earnings (NASDAQ:ELEV)

Ticker Report Elevation Oncology, Inc. (NASDAQ:ELEV - Free Report) - Analysts at HC Wainwright lifted their FY2024 earnings per share estimates for shares of Elevation Oncology in a note issued to investors on...\n more…

HC Wainwright Analysts Boost Earnings Estimates for Elevation Oncology, Inc. (NASDAQ:ELEV)
HC Wainwright Analysts Boost Earnings Estimates for Elevation Oncology, Inc. (NASDAQ:ELEV)

Zolmax Elevation Oncology, Inc. (NASDAQ:ELEV - Free Report) - Equities research analysts at HC Wainwright lifted their FY2024 earnings per share estimates for shares of Elevation Oncology in a research...\n more…